| MeSH term | MeSH ID | Detail |
|---|---|---|
| Coronary Disease | D003327 | 70 associated lipids |
| Insulin Resistance | D007333 | 99 associated lipids |
| Mitochondrial Diseases | D028361 | 25 associated lipids |
Total
3
Palmitoylcarnitine
Palmitoylcarnitine is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 1026 references associated with Palmitoylcarnitine in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for Palmitoylcarnitine
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Palmitoylcarnitine
NCBI Entrez Crosslinks
All references with Palmitoylcarnitine
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Nguyen UT et al. | Small-molecule modulators of Listeria monocytogenes biofilm development. | 2012 | Appl. Environ. Microbiol. | pmid:22194285 |
| Wenderska IB et al. | Palmitoyl-DL-carnitine is a multitarget inhibitor of Pseudomonas aeruginosa biofilm development. | 2011 | Chembiochem | pmid:22045628 |
| Zhang XJ et al. | Measurement of precursor enrichment for calculating intramuscular triglyceride fractional synthetic rate. | 2012 | J. Lipid Res. | pmid:21934122 |
| pmid:21827638 | ||||
| pmid:21492096 | ||||
| Moraru II et al. | Protein kinase C controls Fc gamma receptor-mediated endocytosis in human neutrophils. | 1990 | FEBS Lett. | pmid:2147663 |
| Doi N et al. | Absorption enhancement effect of acylcarnitines through changes in tight junction protein in Caco-2 cell monolayers. | 2011 | Drug Metab. Pharmacokinet. | pmid:21206134 |
| Brandhonneur N et al. | Ex vivo and in vivo diffusion of ropivacaine through spinal meninges: influence of absorption enhancers. | 2011 | Int J Pharm | pmid:21056096 |
| Olson MS et al. | The regulation of pyruvate dehydrogenase by fatty acids in isolated rabbit heart mitochondria. | 1978 | Arch. Biochem. Biophys. | pmid:207223 |
| pmid:2060586 | ||||
| pmid:20563607 | ||||
| Abe K et al. | Phosphorylation of coagulation factor II by phospholipid/Ca(2+)-dependent protein kinase (protein kinase C). | 1991 | Biochem. Biophys. Res. Commun. | pmid:2039497 |
| Butler AP et al. | Involvement of protein kinase C in the regulation of ornithine decarboxylase mRNA by phorbol esters in rat hepatoma cells. | 1991 | Exp. Cell Res. | pmid:2015852 |
| De Jesús VR et al. | Comparison of amino acids and acylcarnitines assay methods used in newborn screening assays by tandem mass spectrometry. | 2010 | Clin. Chim. Acta | pmid:20122909 |
| pmid:2007179 | ||||
| Schaeffer PJ et al. | Impaired contractile function and calcium handling in hearts of cardiac-specific calcineurin b1-deficient mice. | 2009 | Am. J. Physiol. Heart Circ. Physiol. | pmid:19700627 |
| Squire RS | Synthesis and purification of radioactive fatty acylcarnitines of high specific activity. | 1991 | Anal. Biochem. | pmid:1952050 |
| Wu Y et al. | The late Na+ current (INa) inhibitor ranolazine attenuates effects of palmitoyl-L-carnitine to increase late INa and cause ventricular diastolic dysfunction. | 2009 | J. Pharmacol. Exp. Ther. | pmid:19403851 |
| Hoffman DL and Brookes PS | Oxygen sensitivity of mitochondrial reactive oxygen species generation depends on metabolic conditions. | 2009 | J. Biol. Chem. | pmid:19366681 |
| Bonnefont JP et al. | Bezafibrate for an inborn mitochondrial beta-oxidation defect. | 2009 | N. Engl. J. Med. | pmid:19228633 |